Medical Equipment & Supplies Expands Global Reach in Medical Devices; Secures USFDA Registration
Medical Equipment & Supplies Expands Global Reach in Medical Devices; Secures USFDA Registration

Medical Equipment & Supplies Expands Global Reach in Medical Devices; Secures USFDA Registration

Company's products are available both online, through its proprietary store and major e-commerce platforms, and offline, with a presence in over 22,000 retail touchpoints across 460+ towns in India.

DSIJ Intelligence-1 Article rating: 5.0

The company's wholly-owned subsidiary, Nureca Technologies Pvt Ltd, specializes in manufacturing medical devices with an annual capacity of 8 lakh units.

FIIs Increased Their Stake: Multibagger EV-Stock Under Rs 60 Jumps 5.8 Per Cent On April 11; Do You Have It?
FIIs Increased Their Stake: Multibagger EV-Stock Under Rs 60 Jumps 5.8 Per Cent On April 11; Do You Have It?

FIIs Increased Their Stake: Multibagger EV-Stock Under Rs 60 Jumps 5.8 Per Cent On April 11; Do You Have It?

The stock gave multibagger returns of 235 per cent in just 2 years, 6,300 per cent in 3 years and a whopping 15,700 per cent in 5 years.

DSIJ Intelligence-1 Article rating: 3.8

The stock gave multibagger returns of 235 per cent in just 2 years, 6,300 per cent in 3 years and a whopping 15,700 per cent in 5 years.

Only these 29 stocks delivered multibagger returns year-to-date with 17 priced below Rs 100; Full details inside
Only these 29 stocks delivered multibagger returns year-to-date with 17 priced below Rs 100; Full details inside

Only these 29 stocks delivered multibagger returns year-to-date with 17 priced below Rs 100; Full details inside

The total value of all companies listed on the BSE reached approximately Rs 4.13 lakh crore, equivalent to about USD 4.82 trillion.

DSIJ Intelligence-1 Article rating: 4.1

On the same day, 62 stocks hit a 52-week high, while 428 stocks touched a 52-week low.

Understanding Illiquid Securities
Understanding Illiquid Securities

Understanding Illiquid Securities

When we talk about securities, we're referring to financial assets like stocks, bonds, or other investment instruments that can be bought and sold.

DSIJ Intelligence-1 Article rating: 5.0

But not all securities are easy to buy or sell.

SEBI’s February 24, 2025, Consultation Paper: What Every F&O Trader Must Know
SEBI’s February 24, 2025, Consultation Paper: What Every F&O Trader Must Know

SEBI’s February 24, 2025, Consultation Paper: What Every F&O Trader Must Know

Key Highlights from SEBI's Latest Consultation Paper: Enhancing Trading Convenience and Strengthening Risk Monitoring in Equity Derivatives

DSIJ Intelligence Article rating: 4.0

Key Highlights from SEBI's Latest Consultation Paper: Enhancing Trading Convenience and Strengthening Risk Monitoring in Equity Derivatives

Add this Stock to Watchlist: Amid Bear Taking Control Over Indian Equity Market, This Hotel Stock Looks Attractive Considering Growth Potential and Valuation
Add this Stock to Watchlist: Amid Bear Taking Control Over Indian Equity Market, This Hotel Stock Looks Attractive Considering Growth Potential and Valuation

Add this Stock to Watchlist: Amid Bear Taking Control Over Indian Equity Market, This Hotel Stock Looks Attractive Considering Growth Potential and Valuation

Hotel Stock Trades 2 Per Cent Lower Despite Signing a New Property in Rajasthan

DSIJ Intelligence Article rating: 5.0

Hotel Stock Trades 2 Per Cent Lower Despite Signing a New Property in Rajasthan

 

DSIJ MINDSHARE

Mkt Commentary25-Apr, 2025

Mindshare25-Apr, 2025

Mindshare25-Apr, 2025

Mindshare25-Apr, 2025

Multibaggers25-Apr, 2025

Knowledge

MF22-Apr, 2025

MF17-Apr, 2025

General22-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR